Will booster doses be required for serogroup B meningococcal vaccine?
The European licensure of 4CMenB, the first vaccine licensed to prevent non-epidemic meningococcal B (MenB) disease, marked an important milestone in the fight against meningococcal disease. However, the potential introduction of 4CMenB into the routine infant schedule is complicated by a number of...
Main Authors: | McQuaid, F, Snape, MD |
---|---|
格式: | Journal article |
语言: | English |
出版: |
2014
|
相似书籍
-
Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination
由: De Whalley, P, et al.
出版: (2013) -
Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination.
由: de Whalley, P, et al.
出版: (2013) -
Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose.
由: Snape, MD, et al.
出版: (2013) -
Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
由: Snape, M, et al.
出版: (2013) -
Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease.
由: Pollard, A, et al.
出版: (2013)